Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × Busulfan × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 16 Leukemia 15 Myelodysplastic Syndromes 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neuroblastoma 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Sarcoma, Ewing 2 Neoplasms, Plasma Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Graft vs Host Disease 2 Burkitt Lymphoma 2 Anemia, Refractory, with Excess of Blasts 2 Sarcoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1

Interventions

Leucovorin 21 Fluorouracil 21 Capecitabine 20 Docetaxel 18 Gemcitabine 17 Paclitaxel 16 Radiosurgery 14 Irinotecan 14 Oxaliplatin 12 Carboplatin 12 Zoledronic Acid 11 Cisplatin 11 Bevacizumab 11 Radiotherapy 10 Fulvestrant 10 Drug Therapy 9 pembrolizumab 8 palbociclib 8 Pemetrexed 8 Surgical Procedures, Operative 7 Ibandronic Acid 7 abemaciclib 6 Prednisone 6 Letrozole 6 130-nm albumin-bound paclitaxel 6 Vinorelbine 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5 Cetuximab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00987636 2019-10-22

EWING2008

University Hospital Muenster

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡